Clinical trial results
RAE Health completed their first clinical study in 2016 ("Wearable sensor-based detection of stress and craving in patients during treatment for substance use disorders: A mixed methods study") in conjunction with UMASS and two outpatient-based substance abuse treatment facilities. Through this study data was refined and an algorithm derived that was then patented for detection.
• 72.4% accuracy in detecting Stress vs. Craving events
• 83.9% accuracy in detecting Stress vs. No Stress events
• 80.5% accuracy in detecting Cravings vs. No Craving events
NIH funded clinical study :
RAE was awarded SBIR Phase I/II Fast Track in 2019. Phase I was completed February 2021.
SBIR Phase II and Clinical Trial scheduled for 2021
Current accuracy in stress detection is 87%